Home / News / NIH begins a large Phase 3 clinical trial to test immune modulators for the treatment of COVID-19 / Activ
Recent Posts
- Peptides for Weight Loss: What to Know, According to Experts.
- New NJACTS Publication
- Nine Dimensions of Authentic Community Engagement
- Rutgers study finds patients with schizophrenia are less likely to be rehospitalized when given antipsychotic injections.
- Taking Proactive Steps, Rutgers Provides Free Narcan to the Community.
Categories
- News (2,098)
- Publication (1)